Skip to Main Content

Author Details

Noriyuki Kijima
Osaka University Graduate School of Medicine
2011
33
14
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37950432A case of Rosai-Dorfman disease of the central nerve system associated with cutaneous lesions.J Dermatol2024
37404500Surgical resection of glioblastoma in basal ganglia and utility of exoscope: Technical case reports.Surg Neurol Int2023
34089373Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.Cancer Immunol Immunother2022
35855178Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report.Surg Neurol Int2022
36601313Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.Neurooncol Adv2022
35946373[Utility of Neurosurgical Procedures Using 4K 3D Exoscopes: Clinical Experience with a 4K 3D Exoscope and Review of Literature].No Shinkei Geka2022
36115061Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort study.J Neurosurg2022
35171652Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.Sci Transl Med2022
32818237So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Neuro Oncol2021
37501692Endovascular Treatment for Middle Cerebral Artery Aneurysms: Single-Center Experience and Review of Literatures.J Neuroendovasc Ther2021
33520709Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for <i>IDH</i>-Mutant, Non-CODEL Astrocytomas.Front Oncol2021
34867757How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas?Front Neurol2021
34409497Subgroup and subtype-specific outcomes in adult medulloblastoma.Acta Neuropathol2021
34020064The Impact of 5-Year Tumor Doubling Time to Predict the Subsequent Long-Term Natural History of Asymptomatic Meningiomas.World Neurosurg2021
34345480Utility of a novel exoscope, ORBEYE, in gravity-assisted brain retraction surgery for midline lesions of the brain.Surg Neurol Int2021
34355173Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies.Neurooncol Adv2021
34355172Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy.Neurooncol Adv2021
33062567Surgical Treatment of Brain Metastasis of Extramammary Paget's Disease: A Case Report.NMC Case Rep J2020
32097463Chloride intracellular channel 1 cooperates with potassium channel EAG2 to promote medulloblastoma growth.J Exp Med2020
33270750Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.PLoS One2020
31177132Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.Anticancer Res2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
29796184MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.Oncotarget2018
29856958A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.Cell2018
29474906A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.Cell2018
26760213Divergent clonal selection dominates medulloblastoma at recurrence.Nature2016
27238212Molecular Classification of Medulloblastoma.Neurol Med Chir (Tokyo)2016
26976201Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.Lancet Oncol2016
25772149Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.Cancer Immunol Immunother2015
24403445Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.Anticancer Res2014
22166264CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.Neuro Oncol2012
22089887Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.J Neurooncol2012
21136132A survey of disclosure of diagnosis to patients with glioma in Japan.Int J Clin Oncol2011
  • 1 - 33 of 33

Recommended Authors

University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2015
Number of shared co-authors 1
University of Toronto
Career Start Year 2013
Number of shared co-authors 6
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 0
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 8
Queen Mary Hospital
Career Start Year 2009
Number of shared co-authors 2
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 1
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 0
Feinberg School of Medicine, Northwestern University
Career Start Year 2006
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 2
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 10
University of Toronto
Career Start Year 2003
Number of shared co-authors 70
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 8
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 6
Weill Cornell Medical Center, NewYork Presbyterian Hospital
Career Start Year 1998
Number of shared co-authors 3
University of California san francisco
Career Start Year 1997
Number of shared co-authors 2
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 10
University of Minnesota
Career Start Year 1994
Number of shared co-authors 4
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 10
National Cancer Center
Career Start Year 1994
Number of shared co-authors 1
Neuro-Oncology Clinic, National Cancer Center
Career Start Year 1993
Number of shared co-authors 1
University of California san francisco
Career Start Year 1989
Number of shared co-authors 7
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 3
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year 1979
Number of shared co-authors 2

Collaborators

The Hospital for Sick Children
Co-authored papers 9
Hospital for Sick Children
Co-authored papers 7
University of Wollongong
Co-authored papers 6
University of California san francisco
Co-authored papers 6
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 5
University of Toronto
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 5
The Hospital for Sick Children, University of Toronto
Co-authored papers 4
University of Pittsburgh School of Medicine
Co-authored papers 4
The Hospital for Sick Children
Co-authored papers 4
University of Texas MD Anderson Cancer Center Houston
Co-authored papers 4
The Hospital for Sick Children
Co-authored papers 4
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 4
Cumming School of Medicine, University of Calgary
Co-authored papers 4
University of British Columbia
Co-authored papers 4
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 4
BioBox Analytics Inc.
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Seoul National University Children's Hospital
Co-authored papers 4
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Kitasato University School of Medicine
Co-authored papers 4
The Hospital for Sick Children
Co-authored papers 4
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 3
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
Erasmus MC Cancer Institute
Co-authored papers 3
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3